The formation of PanIN lesions and the progression to invasive adenocarcinoma are driven by activation of the KRAS oncogene in about 90% of cases,4 accompanied by loss of function of tumor suppressors, most commonly the Ink4a, p53, and Smad4 tumor suppressors.3 Here, KRAS is linked to neoplasm.